Original language | English (US) |
---|---|
Pages (from-to) | 1756-1760 |
Number of pages | 5 |
Journal | Neurology |
Volume | 77 |
Issue number | 19 |
DOIs | |
State | Published - Nov 8 2011 |
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Neurology, Vol. 77, No. 19, 08.11.2011, p. 1756-1760.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - An enhancing brainstem lesion in a patient with a history of worldwide travel
AU - Roos, K. L.
AU - Gerdes, L. A.
AU - Kurz, K.
AU - Kretzschmar, H.
AU - Kümpfel, T.
AU - Parisi, J. E.
AU - Keegan, B. M.
N1 - Funding Information: Dr. Roos receives funding for travel from the AAN and other universities; serves as Editor-in-Chief of Seminars in Neurology; receives royalties from the publications of 4 textbooks; and gave expert testimony but all monies went to the Department of Neurology at the Indiana University School of Medicine. Dr. Gerdes and Dr. Kurz report no disclosures. Dr. Kretzschmar served on the scientific advisory board for Acta Neuropathologica, Neurogenetics, Brain Pathology, and Translational Neuroscience; receives royalties from the publication of the book Prions in Humans and Animals; receives research support from Federal Ministry of Education and Research, BMG, European Union, and German Research Foundation (DFG); and gave expert testimony for B. Braun Melsungen AG. Dr. Kúmpfel received honoraria for lectures from Bayer Schering Pharma, Teva Pharmaceutical Industries Ltd, Merck Serono, and Biogen Idec (not funded by industry); received funding for travel from Bayer Schering Pharma, Teva Pharmaceutical Industries Ltd, Merck Serono, Novartis, and Biogen Idec; and received research support from Bayer Schering Pharma (not related to this study). Dr. Parisi serves on scientific advisory boards for the US Government Defense Health Board and the Subcommittee for Laboratory Services and Pathology; serves as a Section Editor for Neurology; receives royalties from the publication of Principles & Practice of Neuropathology, 2nd ed. (Oxford University Press, 2003); and receives research support from the NIH. Dr. Keegan serves as Clinical Pathological Conference Section Co-Editor for Neurology and Neurology podcast panel and Chief Editor for eMedicine; and has served as a consultant for Novartis.
PY - 2011/11/8
Y1 - 2011/11/8
UR - http://www.scopus.com/inward/record.url?scp=82955243942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=82955243942&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e318236eec2
DO - 10.1212/WNL.0b013e318236eec2
M3 - Article
C2 - 22067962
AN - SCOPUS:82955243942
SN - 0028-3878
VL - 77
SP - 1756
EP - 1760
JO - Neurology
JF - Neurology
IS - 19
ER -